We are live on ! Find out more
AMYT

Amryt Pharma plc American Depositary Shares
AMYT

Delisted

AMYT was delisted on the 11th of April, 2023.

Back to rankings

57 hedge funds and large institutions have $318M invested in Amryt Pharma plc American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more call options, than puts

Call options by funds: $30K | Put options by funds: $14K

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

1% more capital invested

Capital invested by funds: $315M → $318M (+$2.83M)

8% less funds holding

Funds holding: 62 → 57 (-5)

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Holders
57
Holders Change
-5
Holders Change %
-8.06%
% of All Funds
0.92%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.11%
New
4
Increased
12
Reduced
10
Closed
9
Calls
$30K
Puts
$14K
Net Calls
+$16K
Net Calls Change
+$22K

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$744K
2
ACM
Aquilo Capital Management
California
+$705K
3
Wells Fargo
Wells Fargo
California
+$446K
4
Handelsbanken Fonder
Handelsbanken Fonder
Sweden
+$290K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$219K

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$13.8M
2
AC
Armistice Capital
New York
-$2.07M
3
Millennium Management
Millennium Management
New York
-$852K
4
NAM
Nexpoint Asset Management
Texas
-$277K
5
Citadel Advisors
Citadel Advisors
Florida
-$168K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
Athyrium Capital Management
New York
$64.7M – – –
HCM
2
Highbridge Capital Management
New York
$46.2M – – –
SCM
3
Stonepine Capital Management
Oregon
$46.2M +$744K +105,506 +2%
RCMNY
4
Rubric Capital Management (New York)
New York
$26.3M – – –
MAM
5
MPM Asset Management
Massachusetts
$19.5M – – –
EIG
6
EdgePoint Investment Group
Ontario, Canada
$16.6M – – –
ACM
7
Aquilo Capital Management
California
$15.3M +$705K +100,000 +5%
NCM
8
Nantahala Capital Management
Connecticut
$10.5M – – –
Handelsbanken Fonder
9
Handelsbanken Fonder
Sweden
$10.3M +$290K +41,045 +3%
RSCM
10
Rock Springs Capital Management
Maryland
$9.68M – – –
Man Group
11
Man Group
United Kingdom
$9.56M – – –
AC
12
Armistice Capital
New York
$7.14M -$2.07M -294,000 -23%
CC
13
Clearline Capital
New York
$4.61M – – –
GFI
14
Global Frontier Investments
South Carolina
$3.69M – – –
WA
15
Whitebox Advisors
Minnesota
$3.41M – – –
NLVP
16
New Leaf Venture Partners
New York
$3.28M – – –
BC
17
Bruce & Co
Illinois
$2.3M – – –
SB
18
Samsara BioCapital
California
$2.22M – – –
Wells Fargo
19
Wells Fargo
California
$2.14M +$446K +63,204 +27%
WP
20
Woodline Partners
California
$2.09M -$10.2K -1,439 -0.5%
Ameriprise
21
Ameriprise
Minnesota
$1.73M – – –
SCM
22
Silverarc Capital Management
Massachusetts
$1.41M +$33.1K +4,695 +2%
Millennium Management
23
Millennium Management
New York
$1.01M -$852K -120,735 -47%
TI
24
Telemetry Investments
New York
$951K +$51.2K +7,262 +6%
TC
25
Tejara Capital
United Kingdom
$884K +$855K +121,148 New
1
2 3

AMYT Hedge Fund Activity: Q4 2022 in Review

57 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q4 2022, worth a combined $318M — up 0.9% from $315M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of AMYT and 4 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 12 added.

The largest buyer was Stonepine Capital Management, adding an estimated $744K. The largest seller was UBS O'Connor, exiting entirely with an estimated $13.8M sold.

  • 57 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q4 2022, down from 62 in Q3 2022.
  • Funds reported $318M of Amryt Pharma plc American Depositary Shares stock for Q4 2022, up 0.9% quarter-over-quarter.
  • 4 funds opened new Amryt Pharma plc American Depositary Shares positions in Q4 2022 and 9 closed out, a net change of -5 holders.
  • The largest Amryt Pharma plc American Depositary Shares buyer in Q4 2022 was Stonepine Capital Management, an estimated $744K added.
  • The largest Amryt Pharma plc American Depositary Shares seller in Q4 2022 was UBS O'Connor, an estimated $13.8M sold.

Based on aggregated 13F filings for Q4 2022.